Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
48.69
-0.77 (-1.56%)
At close: Apr 28, 2026, 4:00 PM EDT
47.69
-1.00 (-2.05%)
After-hours: Apr 28, 2026, 4:54 PM EDT
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $2.80 billion as of April 28, 2026. Its market cap has increased by 61.67% in one year.
Market Cap
2.80B
Enterprise Value
2.52B
1-Year Change
61.67%
Ranking
Category
Stock Price
$48.69
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $2.80B, an increase of 1,995.41%. That is a compound annual growth rate of 24.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.85B | -0.06% |
| Dec 31, 2025 | 2.85B | 42.73% |
| Dec 31, 2024 | 2.00B | 26.29% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 3.99B |
| Kiniksa Pharmaceuticals International, | 3.29B |
| Liquidia | 3.29B |
| Prestige Consumer Healthcare | 2.79B |
| HUTCHMED (China) | 2.33B |
| BioCryst Pharmaceuticals | 2.24B |
| Phibro Animal Health | 2.24B |
| Bausch Health Companies | 2.10B |